CombiMOTS: Combinatorial Multi-Objective Tree Search for Dual-Target Molecule Generation

• URL: http://arxiv.org/abs/2604.23307v1
• Date: Sat, 25 Apr 2026 13:44:34 GMT
• Title: CombiMOTS: Combinatorial Multi-Objective Tree Search for Dual-Target Molecule Generation
• Abstract summary: CombiMOTS is a framework that generates dual-target molecules.<n>CombiMOTS produces novel dual-target molecules with high docking scores, enhanced diversity, and balanced pharmacological characteristics.
• Score: 8.288411013805648
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Dual-target molecule generation, which focuses on discovering compounds capable of interacting with two target proteins, has garnered significant attention due to its potential for improving therapeutic efficiency, safety and resistance mitigation. Existing approaches face two critical challenges. First, by simplifying the complex dual-target optimization problem to scalarized combinations of individual objectives, they fail to capture important trade-offs between target engagement and molecular properties. Second, they typically do not integrate synthetic planning into the generative process. This highlights a need for more appropriate objective function design and synthesis-aware methodologies tailored to the dual-target molecule generation task. In this work, we propose CombiMOTS, a Pareto Monte Carlo Tree Search (PMCTS) framework that generates dual-target molecules. CombiMOTS is designed to explore a synthesizable fragment space while employing vectorized optimization constraints to encapsulate target affinity and physicochemical properties. Extensive experiments on real-world databases demonstrate that CombiMOTS produces novel dual-target molecules with high docking scores, enhanced diversity, and balanced pharmacological characteristics, showcasing its potential as a powerful tool for dual-target drug discovery. The code and data is accessible through https://github.com/Tibogoss/CombiMOTS.

Related papers

• Fused Bayesian Flow Networks for Dual-Target Molecular Design [15.474159610462024]
  Dual-target drug design aims to generate 3D molecules that can simultaneously interact with two target proteins.<n>We propose FusedBFN, a fused Bayesian flow network (BFN) for dual-target molecular design.<n>We show that FusedBFN generates molecules with strong binding affinity toward dual targets while maintaining favorable molecular properties.
  arXiv  Detail & Related papers  (2026-08-02T05:23:26Z)
• Don't Retrain, Just Reuse: Recovering Dual-Target Molecules from Single-Target Diffusion Models [20.421741889749573]
  Existing dual-target generative methods introduce dual-target capability by either retraining the generator or intervening in the diffusion process during sampling.<n>We propose REUSE, a hierarchical evolutionary input-space search framework that combines pair-conditioned exploration with structured multi-stage selection to enforce dual-target affinity, chemical quality, and diversity.
  arXiv  Detail & Related papers  (2026-05-25T10:39:16Z)
• Agents on a Tree: Pathwise Coordination for Multi-Objective Molecular Optimization [33.33321738135092]
  Multi-objective molecular optimization requires searching vast chemical spaces under conflicting objectives.<n>We propose ATOM, a multi-agent framework that formulates molecular optimization as a tree-structured search.
  arXiv  Detail & Related papers  (2026-03-27T14:21:21Z)
• ExMolRL: Phenotype-Target Joint Generation of De Novo Molecules via Multi-Objective Reinforcement Learning [4.998189068886174]
  ExMoIRL is a novel generative framework that integrates phenotypic and target-specific cues for de novo molecular generation.<n>It fuses docking affinity and drug-likeness scores, augmented with ranking loss, prior-likelihood regularization, and entropy.<n>Extensive experiments demonstrate ExMoIRL's superior performance over state-of-the-art-based and target-based models.
  arXiv  Detail & Related papers  (2025-09-25T11:13:24Z)
• FragmentGPT: A Unified GPT Model for Fragment Growing, Linking, and Merging in Molecular Design [42.429674313921545]
  FragmentGPT generates linkers to combine disconnected molecular fragments into chemically and pharmacologically viable candidates.<n>It also learns to resolve structural redundancies-such as duplicated fragments-through intelligent merging.<n> experiments and ablation studies on real-world cancer datasets demonstrate its ability to generate chemically valid, high-quality molecules.
  arXiv  Detail & Related papers  (2025-09-14T02:17:07Z)
• Collaborative Expert LLMs Guided Multi-Objective Molecular Optimization [51.104444856052204]
  We present MultiMol, a collaborative large language model (LLM) system designed to guide multi-objective molecular optimization.<n>In evaluations across six multi-objective optimization tasks, MultiMol significantly outperforms existing methods, achieving a 82.30% success rate.
  arXiv  Detail & Related papers  (2025-03-05T13:47:55Z)
• InversionGNN: A Dual Path Network for Multi-Property Molecular Optimization [77.79862482208326]
  InversionGNN is an effective yet sample-efficient dual-path graph neural network (GNN) for multi-objective drug discovery.<n>We train the model for multi-property prediction to acquire knowledge of the optimal combination of functional groups.<n>Then the learned chemical knowledge helps the inversion generation path to generate molecules with required properties.
  arXiv  Detail & Related papers  (2025-03-03T12:53:36Z)
• DrugImproverGPT: A Large Language Model for Drug Optimization with Fine-Tuning via Structured Policy Optimization [53.27954325490941]
  Finetuning a Large Language Model (LLM) is crucial for generating results towards specific objectives.<n>This research introduces a novel reinforcement learning algorithm to finetune a drug optimization LLM-based generative model.
  arXiv  Detail & Related papers  (2025-02-11T04:00:21Z)
• Pareto Optimization to Accelerate Multi-Objective Virtual Screening [11.356174411578515]
  We develop a tool to search a virtual library of over 4M molecules for those predicted to be selective dual inhibitors of EGFR and IGF1R. This workflow and associated open source software can reduce the screening burden of molecular design projects.
  arXiv  Detail & Related papers  (2023-10-16T17:19:46Z)
• LIMO: Latent Inceptionism for Targeted Molecule Generation [14.391216237573369]
  We present Latent Inceptionism on Molecules (LIMO), which significantly accelerates molecule generation with an inceptionism-like technique. Comprehensive experiments show that LIMO performs competitively on benchmark tasks. One of our generated drug-like compounds has a predicted $K_D$ of $6 cdot 10-14$ M against the human estrogen receptor.
  arXiv  Detail & Related papers  (2022-06-17T21:05:58Z)
• Optimizing Molecules using Efficient Queries from Property Evaluations [66.66290256377376]
  We propose QMO, a generic query-based molecule optimization framework. QMO improves the desired properties of an input molecule based on efficient queries. We show that QMO outperforms existing methods in the benchmark tasks of optimizing small organic molecules.
  arXiv  Detail & Related papers  (2020-11-03T18:51:18Z)
• MIMOSA: Multi-constraint Molecule Sampling for Molecule Optimization [51.00815310242277]
  generative models and reinforcement learning approaches made initial success, but still face difficulties in simultaneously optimizing multiple drug properties. We propose the MultI-constraint MOlecule SAmpling (MIMOSA) approach, a sampling framework to use input molecule as an initial guess and sample molecules from the target distribution.
  arXiv  Detail & Related papers  (2020-10-05T20:18:42Z)
• CogMol: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models [74.58583689523999]
  We propose an end-to-end framework, named CogMol, for designing new drug-like small molecules targeting novel viral proteins. CogMol combines adaptive pre-training of a molecular SMILES Variational Autoencoder (VAE) and an efficient multi-attribute controlled sampling scheme. CogMol handles multi-constraint design of synthesizable, low-toxic, drug-like molecules with high target specificity and selectivity.
  arXiv  Detail & Related papers  (2020-04-02T18:17:20Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.